Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in AVBP — ArriVent BioPharma, Inc.

CIK 70858 CHARLOTTE, NC
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,074,844
+$4,224,446 QoQ
Shares Held
174,866
+118.0% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. AVBP ranks #132 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,074,844 174,866
2026-03-31 $1,850,398 80,208
2025-12-31 $1,137,202 56,521
2025-09-30 $848,275 45,977
2025-06-30 $669,361 30,747
2025-03-31 $541,479 29,285
2024-12-31 $1,213,292 45,544
2024-09-30 $1,016,727 43,265
2024-06-30 $116,882 6,301
2024-03-31 $40,345 2,259